Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Class B GPCRs: a hidden agonist within?

Martin Beinborn1

  • 1Molecular Pharmacology Research Center, Molecular Cardiology Research Institute, Tufts-New England Medical Center, 15 Kneeland Street, Boston, MA 02111, USA. mbeinborn@tufts-nemc.org

Molecular Pharmacology
|April 25, 2006
PubMed
Summary

Class B G protein-coupled receptors (GPCRs) are activated by a novel mechanism. A hidden epitope on the receptor, exposed by hormones, acts as the true agonist, enabling small molecule drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amping Up Receptor Balance and Bias: Fine Tuning of Unimolecular Multiagonists.

Journal of medicinal chemistry·2026
Same author

Molecular Design of Unimolecular Tetra-Receptor Agonists.

Journal of the American Chemical Society·2025
Same author

Potent and Protease Resistant Azapeptide Agonists of the GLP-1 and GIP Receptors.

Angewandte Chemie (International ed. in English)·2024
Same author

Prolonged Activation of the GLP-1 Receptor via Covalent Capture.

ACS chemical biology·2024
Same author

Molecular design of peptide therapeutics via N-terminal modification.

Methods in enzymology·2024
Same author

A Robust Platform for the Molecular Design of Potent, Protease-Stable, Long-Acting GIP Analogues.

Journal of medicinal chemistry·2024

Area of Science:

  • Endocrinology
  • Neuroendocrinology
  • Pharmacology

Background:

  • Class B G protein-coupled receptors (GPCRs) mediate crucial endocrine and neuroendocrine functions.
  • Current models propose peptide hormones bind GPCRs via carboxyl and amino termini to initiate signaling.

Discussion:

  • Dong et al. present an alternative model for class B GPCR activation using the secretin receptor.
  • The study suggests endogenous peptide hormones do not directly activate GPCRs but expose a hidden receptor epitope.

Key Insights:

  • Oligopeptide fragments of the secretin receptor's amino terminus act as potent agonists.
  • These non-conventional agonists, even tripeptides, mimic hormone function without sequence homology.
  • This reveals a novel paradigm of ligand-induced receptor activation.

Outlook:

  • This discovery may pave the way for developing small molecule agonists for class B GPCRs.
  • Facilitates the search for therapeutics targeting this important receptor class.

Related Experiment Videos